Company / Assets per Share
Perspective Therapeutics, Inc. Assets per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.41
FY2022
5-year range
$0.13 / $1.02
FY2018-FY2022
Trend
-59.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has fluctuated over the past 10 years, ranging from $0.13 in FY2020 to $1.02 in FY2021.
Based on SEC 10-K filings.
0.41 in FY2022 with a 5-year CAGR of +12.9%.
Improved from $0.13 to $0.41 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +34.8%
- 5-Year CAGR
- +12.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, assets per share decreased 59.9% year-over-year.
- Peak assets per share was recorded in FY2021.
- Lowest assets per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.41 | -59.9% |
| FY2021 | $1.02 | +691.7% |
| FY2020 | $0.13 | -22.8% |
| FY2019 | $0.17 | +23.4% |
| FY2018 | $0.14 | -39.2% |
| FY2017 | $0.22 | -48.8% |
| FY2016 | $0.44 | -21.3% |
| FY2015 | $0.55 | -27.8% |
| FY2014 | $0.77 | +236.4% |
| FY2013 | $0.23 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026